These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25073425)

  • 1. Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus.
    Mechlovich D; Amit T; Bar-Am O; Weinreb O; Youdim MB
    Br J Pharmacol; 2014 Dec; 171(24):5636-49. PubMed ID: 25073425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.
    Kupershmidt L; Weinreb O; Amit T; Mandel S; Bar-Am O; Youdim MB
    Neuroscience; 2011 Aug; 189():345-58. PubMed ID: 21570450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice.
    Mechlovich D; Amit T; Bar-Am O; Mandel S; Youdim MB; Weinreb O
    Curr Alzheimer Res; 2014 Feb; 11(2):119-27. PubMed ID: 24359498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30.
    Avramovich-Tirosh Y; Bar-Am O; Amit T; Youdim MB; Weinreb O
    Curr Alzheimer Res; 2010 Jun; 7(4):300-6. PubMed ID: 20043814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Weinreb O
    Antioxid Redox Signal; 2012 Sep; 17(6):860-77. PubMed ID: 22360429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis.
    Kupershmidt L; Weinreb O; Amit T; Mandel S; Carri MT; Youdim MB
    FASEB J; 2009 Nov; 23(11):3766-79. PubMed ID: 19638399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism.
    Pollak Y; Mechlovich D; Amit T; Bar-Am O; Manov I; Mandel SA; Weinreb O; Meyron-Holtz EG; Iancu TC; Youdim MB
    J Neural Transm (Vienna); 2013 Jan; 120(1):37-48. PubMed ID: 22446839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Golko-Perez S; Mandel S; Amit T; Kupershmidt L; Youdim MB; Weinreb O
    Neurotox Res; 2016 Feb; 29(2):208-17. PubMed ID: 26581376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage.
    Mechlovich D; Amit T; Mandel SA; Bar-Am O; Bloch K; Vardi P; Youdim MB
    J Pharmacol Exp Ther; 2010 Jun; 333(3):874-82. PubMed ID: 20237072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.
    Gal S; Abassi ZA; Youdim MB
    Neurotox Res; 2010 Aug; 18(2):143-50. PubMed ID: 19894083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
    Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O
    Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.
    Sofic E; Salkovic-Petrisic M; Tahirovic I; Sapcanin A; Mandel S; Youdim M; Riederer P
    J Neural Transm (Vienna); 2015 Apr; 122(4):559-64. PubMed ID: 25252744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1(G93A) Transgenic ALS Mice.
    Golko-Perez S; Amit T; Youdim MB; Weinreb O
    J Mol Neurosci; 2016 Aug; 59(4):504-10. PubMed ID: 27173029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Weinreb O
    Mech Ageing Dev; 2012 May; 133(5):267-74. PubMed ID: 22426424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease.
    Gal S; Fridkin M; Amit T; Zheng H; Youdim MB
    J Neural Transm Suppl; 2006; (70):447-56. PubMed ID: 17017567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice.
    Kupershmidt L; Amit T; Bar-Am O; Weinreb O; Youdim MB
    Mol Neurobiol; 2012 Aug; 46(1):217-20. PubMed ID: 22847630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30.
    Gal S; Zheng H; Fridkin M; Youdim MB
    Neurotox Res; 2010 Jan; 17(1):15-27. PubMed ID: 19609632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.